MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
MAIA is expected to report earnings to rise 56.25% to -25 cents per share on August 05
Q2'25
Est.
$-0.25
Q1'25
Beat
by $0.02
Q4'24
Beat
by $0.03
Q3'24
Beat
by $0.12
Q2'24
Missed
by $0.09
The last earnings report on May 05 showed earnings per share of -15 cents, beating the estimate of -18 cents. With 995.10K shares outstanding, the current market capitalization sits at 54.16M.